• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇链长对壳聚糖/siRNA 纳米粒物理性质和体内外生物活性的影响。

Impact of PEG Chain Length on the Physical Properties and Bioactivity of PEGylated Chitosan/siRNA Nanoparticles in Vitro and in Vivo.

机构信息

Interdisciplinary Nanoscience Center (iNANO), Aarhus University , DK-8000 Aarhus C, Denmark.

Department of Molecular Biology and Genetics, Aarhus University , DK-8000 Aarhus C, Denmark.

出版信息

ACS Appl Mater Interfaces. 2017 Apr 12;9(14):12203-12216. doi: 10.1021/acsami.6b16556. Epub 2017 Apr 3.

DOI:10.1021/acsami.6b16556
PMID:28332829
Abstract

PEGylation of cationic polyplexes is a promising approach to enhance the stability and reduce unspecific interaction with biological components. Herein, we systematically investigate the impact of PEGylation on physical and biological properties of chitosan/siRNA polyplexes. A series of chitosan-PEG copolymers (CS-PEG2k, CS-PEG5k and CS-PEG10k) were synthesized with similar PEG mass content but with different molecular weight. PEGylation with higher molecular weight and less grafting degree resulted in smaller and more compacted nanoparticles with relatively higher surface charge. PEGylated polyplexes showed distinct mechanism of endocytosis, which was macropinocytosis and caveolae-dependent and clathrin-independent. In vitro silencing efficiency in HeLa and H1299 cells was significantly improved by PEGylation and CS-PEG5k/siRNA achieved the highest knockdown efficiency. Efficient silence of ribonucleotide reductase subunit M2 (RRM2) in HeLa cells by CS-PEG5k/siRRM2 significantly induced cell cycle arrest and inhibited cell proliferation. In addition, PEGylation significantly inhibited macrophage phagocytosis and unspecific interaction with red blood cells (RBCs). Significant extension of in vivo circulation was achieved only with high molecular weight PEG modification (CS-PEG10k), whereas all CS/siRNA and CS-PEG/siRNA nanoparticles showed similar pattern of biodistribution with major accumulation in liver and kidney. These results imply that PEGylation with higher molecular weight PEG and less grafting rate is a promising strategy to improve chitosan/siRNA nanocomplexes performance both in vitro and in vivo.

摘要

聚乙二醇化阳离子聚合物多聚物是提高稳定性和降低与生物成分非特异性相互作用的一种很有前途的方法。在此,我们系统地研究了聚乙二醇化对壳聚糖/ siRNA 聚合物多聚物的物理和生物学性质的影响。用相似的聚乙二醇质量含量但不同分子量合成了一系列壳聚糖-聚乙二醇共聚物(CS-PEG2k、CS-PEG5k 和 CS-PEG10k)。分子量更高和接枝率更低的聚乙二醇化导致更小和更紧凑的纳米粒子,具有相对较高的表面电荷。聚乙二醇化聚合物多聚物表现出不同的内吞作用机制,这是巨胞饮和网格蛋白独立的、依赖于小窝蛋白的。在 HeLa 和 H1299 细胞中,聚乙二醇化显著提高了体外沉默效率,CS-PEG5k/siRNA 达到了最高的沉默效率。CS-PEG5k/siRRM2 对 HeLa 细胞中核糖核苷酸还原酶亚基 M2(RRM2)的有效沉默显著诱导了细胞周期停滞并抑制了细胞增殖。此外,聚乙二醇化显著抑制了巨噬细胞的吞噬作用和与红细胞(RBC)的非特异性相互作用。只有高分子量 PEG 修饰(CS-PEG10k)才能显著延长体内循环时间,而所有 CS/siRNA 和 CS-PEG/siRNA 纳米颗粒在体内分布模式相似,主要在肝和肾中积累。这些结果表明,高分子量 PEG 和较低接枝率的聚乙二醇化是提高壳聚糖/siRNA 纳米复合物在体外和体内性能的一种很有前途的策略。

相似文献

1
Impact of PEG Chain Length on the Physical Properties and Bioactivity of PEGylated Chitosan/siRNA Nanoparticles in Vitro and in Vivo.聚乙二醇链长对壳聚糖/siRNA 纳米粒物理性质和体内外生物活性的影响。
ACS Appl Mater Interfaces. 2017 Apr 12;9(14):12203-12216. doi: 10.1021/acsami.6b16556. Epub 2017 Apr 3.
2
Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.基于壳聚糖的纳米颗粒用于在乳腺癌治疗中靶向递送生存素小干扰RNA并防止其转移。
Int J Nanomedicine. 2016 Sep 27;11:4931-4945. doi: 10.2147/IJN.S105427. eCollection 2016.
3
Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity.对壳聚糖进行优化的聚乙二醇化处理以保持最佳的 siRNA 纳米复合物的生物活性。
Carbohydr Polym. 2016 Jun 5;143:25-34. doi: 10.1016/j.carbpol.2016.01.010. Epub 2016 Jan 8.
4
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.离子交联叶酸-聚(乙二醇)-壳寡糖乳酸纳米粒介导的高效siRNA递送及肿瘤蓄积:用于潜在的靶向卵巢癌基因治疗
Eur J Pharm Sci. 2014 Feb 14;52:48-61. doi: 10.1016/j.ejps.2013.10.011. Epub 2013 Oct 29.
5
Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.使用四谷氨酸化叶酸作为配体进行受体靶向递送的小干扰RNA脂质寡氨基酰胺多聚体的聚乙二醇化后修饰
Mol Pharm. 2016 Jul 5;13(7):2332-45. doi: 10.1021/acs.molpharmaceut.6b00102. Epub 2016 May 31.
6
Fine tuning neuronal targeting of nanoparticles by adjusting the ligand grafting density and combining PEG spacers of different length.通过调整配体接枝密度和结合不同长度的 PEG 间隔物来精细调整纳米颗粒的神经元靶向性。
Acta Biomater. 2018 Sep 15;78:247-259. doi: 10.1016/j.actbio.2018.08.005. Epub 2018 Aug 7.
7
Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.利用非共价 PEG 化壳聚糖纳米粒递呈靶向肿瘤代谢的 siRNA:鉴定配体结构、连接子和接枝方法的最佳组合。
J Control Release. 2016 Feb 10;223:53-63. doi: 10.1016/j.jconrel.2015.12.020. Epub 2015 Dec 14.
8
Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.壳聚糖接枝-(PEI-β-环糊精)共聚物及其超分子聚乙二醇化用于 DNA 和 siRNA 的递送。
Biomaterials. 2011 Nov;32(32):8328-41. doi: 10.1016/j.biomaterials.2011.07.038. Epub 2011 Aug 15.
9
Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer.离子交联壳聚糖纳米粒作为基因传递系统:PEG 化程度对体外和体内基因转染的影响。
J Biomed Nanotechnol. 2009 Apr;5(2):162-71. doi: 10.1166/jbn.2009.1017.
10
In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.各种聚乙烯亚胺(-聚乙二醇)/小干扰RNA复合物的体内药代动力学、组织分布及潜在机制
Toxicol Appl Pharmacol. 2009 Apr 1;236(1):97-108. doi: 10.1016/j.taap.2009.01.014. Epub 2009 Jan 29.

引用本文的文献

1
Formulation-Driven Optimization of PEG-Lipid Content in Lipid Nanoparticles for Enhanced mRNA Delivery In Vitro and In Vivo.脂质纳米颗粒中聚乙二醇脂质含量的配方驱动优化以增强mRNA在体外和体内的递送
Pharmaceutics. 2025 Jul 22;17(8):950. doi: 10.3390/pharmaceutics17080950.
2
Receptor-Mediated Internalization of L-Asparaginase into Tumor Cells Is Suppressed by Polyamines.多胺抑制L-天冬酰胺酶通过受体介导的方式内化进入肿瘤细胞。
Int J Mol Sci. 2025 Jul 14;26(14):6749. doi: 10.3390/ijms26146749.
3
Development, Characterization, and Evaluation of Chi-Tn mAb-Functionalized DOTAP-PLGA Hybrid Nanoparticles Loaded with Docetaxel for Lung Cancer Therapy.
用于肺癌治疗的负载多西他赛的壳聚糖-转铁蛋白单克隆抗体功能化DOTAP-PLGA杂化纳米颗粒的研发、表征及评价
Pharmaceutics. 2025 Jan 25;17(2):164. doi: 10.3390/pharmaceutics17020164.
4
Topical delivery of siRNA to psoriatic skin model using high molecular weight chitosan derivatives: In vitro and in vivo studies.使用高分子量壳聚糖衍生物将小干扰RNA局部递送至银屑病皮肤模型:体外和体内研究
Drug Deliv Transl Res. 2025 Feb 5. doi: 10.1007/s13346-025-01800-4.
5
mRNA delivery enabled by metal-organic nanoparticles.金属有机纳米粒子介导的 mRNA 递送。
Nat Commun. 2024 Nov 8;15(1):9664. doi: 10.1038/s41467-024-53969-w.
6
Disulfide Cross-Linked Polymeric Redox-Responsive Nanocarrier Based on Heparin, Chitosan and Lipoic Acid Improved Drug Accumulation, Increased Cytotoxicity and Selectivity to Leukemia Cells by Tumor Targeting via "Aikido" Principle.基于肝素、壳聚糖和硫辛酸的二硫键交联聚合物氧化还原响应纳米载体通过“合气道”原理实现肿瘤靶向,改善药物积累,增强对白血病细胞的细胞毒性和选择性。
Gels. 2024 Feb 20;10(3):157. doi: 10.3390/gels10030157.
7
Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer.基于金纳米粒子的靶向药物递送系统对胰腺癌的体内分布和治疗效果。
Cancer Lett. 2024 May 1;589:216810. doi: 10.1016/j.canlet.2024.216810. Epub 2024 Mar 15.
8
Exploring the impact of PEGylation on pharmacokinetics: a size-dependent effect of polyethylene glycol on prostate-specific membrane antigen inhibitors.探索聚乙二醇化对药代动力学的影响:聚乙二醇对前列腺特异性膜抗原抑制剂的大小依赖性效应。
EJNMMI Res. 2024 Feb 7;14(1):15. doi: 10.1186/s13550-024-01071-z.
9
Potential role of Chinese medicine nanoparticles to treat coronary artery disease.中药纳米颗粒在治疗冠状动脉疾病中的潜在作用。
Heliyon. 2023 Sep 1;9(9):e19766. doi: 10.1016/j.heliyon.2023.e19766. eCollection 2023 Sep.
10
A Comprehensive Review on Prospects of Polymeric Nanoparticles for Treatment of Diabetes Mellitus: Receptors-Ligands, & Studies.聚合物纳米颗粒治疗糖尿病的前景综述:受体 - 配体及研究
Recent Pat Nanotechnol. 2024;18(4):457-478. doi: 10.2174/1872210517666230803091245.